Hemolytic hyperbilirubinemia after percutaneous device closure of left ventricular pseudoaneurysm: A disregarded complication

Meng-Ta Tsai, Cheng Che Tseng, Chung-Dann Kan

Research output: Contribution to journalArticle

Abstract

Surgical repair of a left ventricular pseudoaneurysm is challenging. Percutaneous closure with an AMPLATZER Septal Occluder (AGA Medical Corporation, Golden Valley, MN) has evolved to be an effective alternative to conventional surgery with less complication. We report a case of severe hemolytic hyperbilirubinemia and acute renal failure after percutaneous left ventricular pseudoaneurysm endoprothesis repair, which required conventional surgical repair through a left thoracotomy to treat this complication. The rationale and results of such an off-the-label usage of AMPLATZER Septal Occluder were reexamined. Residual leakages were not rare findings in the reviewed literature. The indications for this approach should be individualized.

Original languageEnglish
Pages (from-to)707-709
Number of pages3
JournalAnnals of Thoracic Surgery
Volume95
Issue number2
DOIs
Publication statusPublished - 2013 Feb 1

Fingerprint

Septal Occluder Device
Hyperbilirubinemia
False Aneurysm
Equipment and Supplies
Thoracotomy
Acute Kidney Injury

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

@article{80fa2d2365664be58c826f190864b4ee,
title = "Hemolytic hyperbilirubinemia after percutaneous device closure of left ventricular pseudoaneurysm: A disregarded complication",
abstract = "Surgical repair of a left ventricular pseudoaneurysm is challenging. Percutaneous closure with an AMPLATZER Septal Occluder (AGA Medical Corporation, Golden Valley, MN) has evolved to be an effective alternative to conventional surgery with less complication. We report a case of severe hemolytic hyperbilirubinemia and acute renal failure after percutaneous left ventricular pseudoaneurysm endoprothesis repair, which required conventional surgical repair through a left thoracotomy to treat this complication. The rationale and results of such an off-the-label usage of AMPLATZER Septal Occluder were reexamined. Residual leakages were not rare findings in the reviewed literature. The indications for this approach should be individualized.",
author = "Meng-Ta Tsai and Tseng, {Cheng Che} and Chung-Dann Kan",
year = "2013",
month = "2",
day = "1",
doi = "10.1016/j.athoracsur.2012.06.020",
language = "English",
volume = "95",
pages = "707--709",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Hemolytic hyperbilirubinemia after percutaneous device closure of left ventricular pseudoaneurysm

T2 - A disregarded complication

AU - Tsai, Meng-Ta

AU - Tseng, Cheng Che

AU - Kan, Chung-Dann

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Surgical repair of a left ventricular pseudoaneurysm is challenging. Percutaneous closure with an AMPLATZER Septal Occluder (AGA Medical Corporation, Golden Valley, MN) has evolved to be an effective alternative to conventional surgery with less complication. We report a case of severe hemolytic hyperbilirubinemia and acute renal failure after percutaneous left ventricular pseudoaneurysm endoprothesis repair, which required conventional surgical repair through a left thoracotomy to treat this complication. The rationale and results of such an off-the-label usage of AMPLATZER Septal Occluder were reexamined. Residual leakages were not rare findings in the reviewed literature. The indications for this approach should be individualized.

AB - Surgical repair of a left ventricular pseudoaneurysm is challenging. Percutaneous closure with an AMPLATZER Septal Occluder (AGA Medical Corporation, Golden Valley, MN) has evolved to be an effective alternative to conventional surgery with less complication. We report a case of severe hemolytic hyperbilirubinemia and acute renal failure after percutaneous left ventricular pseudoaneurysm endoprothesis repair, which required conventional surgical repair through a left thoracotomy to treat this complication. The rationale and results of such an off-the-label usage of AMPLATZER Septal Occluder were reexamined. Residual leakages were not rare findings in the reviewed literature. The indications for this approach should be individualized.

UR - http://www.scopus.com/inward/record.url?scp=84872794955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872794955&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2012.06.020

DO - 10.1016/j.athoracsur.2012.06.020

M3 - Article

C2 - 23336887

AN - SCOPUS:84872794955

VL - 95

SP - 707

EP - 709

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -